The use of thiazides in chronic kidney disease

Current Hypertension Reviews

Volumn 10, Issue 2, 2014, Pages 81-85

  Karadsheh, Feras ^a   Weir, Matthew R ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Antihypertensive drug therapy; Blood pressure; Chronic kidney disease; CKD; GFR; Glomerular filtration rate; Hypertension; Loop diuretics; Thiazide; Thiazide like diuretics

Indexed keywords

THIAZIDE DIURETIC AGENT; DIURETIC AGENT;

ARTICLE; BLOOD PRESSURE; CHRONIC KIDNEY DISEASE; DRUG EFFECT; DRUG HALF LIFE; DRUG SELECTIVITY; DRUG USE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; META ANALYSIS (TOPIC); NONHUMAN; OUTCOME ASSESSMENT; PHARMACODYNAMICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); VOLUME OF DISTRIBUTION; CHRONIC KIDNEY FAILURE; COMPLICATION; TREATMENT OUTCOME;

DIURETICS; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; RENAL INSUFFICIENCY, CHRONIC; THIAZIDES; TREATMENT OUTCOME;

EID: 84921788912     PISSN: 15734021     EISSN: 18756506     Source Type: Journal    
DOI: 10.2174/1573402111666141231150213     Document Type: Article

References (45)

1. Coresh J, Wei GL, McQuillan G, et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 2001; 161: 1207-16.
2. Hollander W, Wilkins RW. Chlorothiazide: a new type of drug for the treatment of arterial hypertension. BMQ 1957; 8(3): 69-75.
3. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991; 265(24): 3255-64.
4. Cutler JA, MacMahon S., Furberg CD. Controlled clinical trials of drug treatment for hypertension. A review. Hypertension 1989; 13(5 Suppl): I36-44.
5. Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 1997; 277(9): 739-45.
6. Collins R, Peto R, Godwin J, MacMahon S. Blood pressure and coronary heart disease. Lancet 1990; 336(8711): 370-1.
7. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288(23): 2981-97.
8. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42(6): 1206-52.
9. Schreiner GE. Chlorothiazide in renal disease. Ann N Y Acad Sci 1958; 71(4): 420-9.
10. Reubi FC, Cottier PT. Effects of reduced glomerular filtration rate on responsiveness to chlorothiazide and mercurial diuretics. Circulation 1961; 23: 200-10.
11. Duarte JD, Cooper-DeHoff RM. Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics. Expert Rev Cardiovasc Ther 2010; 8(6): 793-802.
12. Ellison DH, Velazquez H, Wright FS. Thiazide-sensitive sodium chloride cotransport in early distal tubule. Am J Physiol 1987; 253(3 Pt 2): F546-54.
13. Eladari D, Chambrey R. Identification of a novel target of thiazide diuretics. J Nephrol 2011; 24(4): 391-4.
14. Pickkers P, Hughes AD, Russel FG, Thien T, Smits P. Thiazideinduced vasodilation in humans is mediated by potassium channel activation. Hypertension 1998; 32(6): 1071-6.
15. Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension 2004; 43(1): 4-9.
16. Allen JH, McKenney JM, Stratton MA, Link K. Antihypertensive effect of hydrochlorothiazide administered once or twice daily. Clin Pharm 1982; 1(3): 239-43.
17. De Plaen JF, Vander EE, Van Ypersele de SC. Penbutolol or hydrochlorothiazide once a day in hypertension. A controlled study with home measurements. Br J Clin Pharmacol 1981; 12(2): 215-21.
18. Cushman WC, Khatri I, Materson BJ, et al. Treatment of hypertension in the elderly. III. Response of isolated systolic hypertension to various doses of hydrochlorothiazide: results of a Department of Veterans Affairs cooperative study. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch Intern Med 1991; 151(10): 1954-60.
19. Kohvakka A, Salo H, Gordin A, Eisalo A. Antihypertensive and biochemical effects of different doses of hydrochlorothiazide alone or in combination with triamterene. Acta Med Scand 1986; 219(4): 381-6.
20. Peterzan MA, Hardy R, Chaturvedi N, Hughes AD. Meta-Analysis of Dose-Response Relationships for Hydrochlorothiazide, Chlorthalidone, and Bendroflumethiazide on Blood Pressure, Serum Potassium, and Urate. Hypertension 2012; 59(6): 1104-9.
21. Black HR. The evolution of low-dose diuretic therapy: the lessons from clinical trials. Am J Med 1996; 101(3A): 47S-52S.
22. Flack JM1, Cushman WC. Evidence for the efficacy of low-dose diuretic monotherapy. Am J Med 1996; 101(3A): 53S-60S.
23. Bengtsson C, Johnsson G, Sannerstedt R, Werko L. Effect of different doses of chlorthalidone on blood pressure, serum potassium, and serum urate. Br Med J 1975; 1(5951): 197-9.
24. Grimm RH, Jr., Neaton JD, McDonald M, et al. Beneficial effects from systematic dosage reduction of the diuretic, chlorthalidone: a randomized study within a clinical trial. Am Heart J 1985; 109(4): 858-64.
25. van BP, Man in 't Veld AJ, Schalekamp MA. Hemodynamic changes during long-term thiazide treatment of essential hypertension in responders and nonresponders. Clin Pharmacol Ther 1980; 27(3): 328-36.
26. Materson BJ, Oster JR, Michael UF, et al. Dose response to chlorthalidone in patients with mild hypertension. Efficacy of a lower dose. Clin Pharmacol Ther 1978; 24(2): 192-8.
27. Wing LM, Reid CM, Ryan P, et al. Second Australian National Blood Pressure Study (ANBP2). Australian Comparative Outcome Trial of ACE inhibitor- and diuretic-based treatment of hypertension in the elderly. Management Committee on behalf of the High Blood Pressure Research Council of Australia. Clin Exp Hypertens 1997; 19(5-6): 779-91.
28. Dorsch MP, Gillespie BW, Erickson SR, Bleske BE, Weder AB. Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis. Hypertension 2011; 57(4): 689-94.
29. Conway J, Lauwers P. Hemodynamic and hypotensive effects of long-term therapy with chlorothiazide. Circulation 1960; 21: 21-7.
30. Wilson IM, Freis ED. Relationship between plasma and extracellular fluid volume depletion and the antihypertensive effect of chlorothiazide. Circulation 1959; 20: 1028-36.
31. Winer BM. The antihypertensive actions of benzothiadiazines. Circulation 1961; 23: 211-8.
32. Aleksandrow D, Wysznacka W, Gajewski J. Influence of chlorothiazide upon arterial responsiveness to nor-epinephrine in hypertensive subjects. N Engl J Med 1959; 261: 1052-5.
33. Freis ED, Wanko A, Schnaper HW, Frohlich ED. Mechanism of the altered blood pressure responsiveness produced by chlorothiazide. J Clin Invest 1960; 39: 1277-81.
34. Zhu Z, Zhu S, Liu D, Cao T, Wang L, Tepel M. Thiazide-like diuretics attenuate agonist-induced vasoconstriction by calcium desensitization linked to Rho kinase. Hypertension 2005; 45(2): 233-9.
35. Colas B, Slama M, Collin T, Safar M, Andrejak M. Mechanisms of methyclothiazide-induced inhibition of contractile responses in rat aorta. Eur J Pharmacol 2000; 408(1): 63-7.
36. Hughes AD. How do thiazide and thiazide-like diuretics lower blood pressure? J Renin Angiotensin Aldosterone Syst 2004; 5(4): 155-60.
37. Pickkers P, Hughes AD, Russel FG, Thien T, Smits P. In vivo evidence for K(Ca) channel opening properties of acetazolamide in the human vasculature. Br J Pharmacol 2001; 132(2): 443-50.
38. Dussol B, Moussi-Frances J, Morange S, Somma-Delpero C, Mundler O, Berland Y. A pilot study comparing furosemide and hydrochlorothiazide in patients with hypertension and stage 4 or 5 chronic kidney disease. J Clin Hypertens (Greenwich) 2012; 14(1): 32-7.
39. Jones B, Nanra RS. Double-blind trial of antihypertensive effect of chlorothiazide in severe renal failure. Lancet 1979; 2(8155): 1258-60.
40. Tobian L. Why do thiazide diuretics lower blood pressure in essential hypertension? Annu Rev Pharmacol 1967; 7: 399-408.
41. Dussol B, Moussi-Frances J, Morange S, Somma-Delpero C, Mundler O, Berland Y. A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension. Nephrol Dial Transplant 2005; 20(2): 349-53.
42. Knauf H, Mutschler E. Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure. J Cardiovasc Pharmacol 1995; 26(3): 394-400.
43. Bricker NS, Fine LG, Kaplan M, Epstein M, Bourgoignie JJ, Light A. Magnification phenomenon" in chronic renal disease. N Engl J Med 1978; 299(23): 1287-93.
44. Agarwal R, Sinha AD, Pappas MK, Ammous F. Chlorthalidone for Poorly Controled Hypertension in Chronic Kidney Disease: An interventional Pilot Study. Am J nephrol 2014; 39: 171-82.
45. Cirillo M, Marcarelli F, Mele AA, Romano M, Lombardi C, Bilancio G. Parallel-Group 8-Weeks Study on Chlorthalidone Effects in Hypertensives With low Kidney Function. Hypertension 2014; 63(4): 692-7.